Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$11.69
EPS est.
$11.56
EPS surprise
+1.14%
1-day move
+1.49%
McKesson's earnings report shows a positive surprise in EPS, which likely contributed to the stock's increase of 1.49%. However, the lack of revenue data and management commentary leaves some uncertainty about the overall performance and future outlook. Investors may be encouraged by the EPS beat but will need more information to assess the company's trajectory.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $11.69 | $11.57 | +1.14% |
| Revenue | N/A | $101.3B | N/A |
No transcript is on record, so the analysis is based solely on numerical results. There is no additional commentary available from management.
McKesson Corporation is a leading health care distributor that provides pharmaceuticals and medical supplies to hospitals, pharmacies, and other health care providers. With a market cap of $92 billion, it plays a crucial role in the health care supply chain, especially as demand for health services continues to grow.
Last quarter
In Q3-2026, McKesson reported an EPS of $9.34, slightly beating expectations. However, the stock fell 3.42% the following day, indicating some investor disappointment.
EPS beat streak
4Q
EPS beat rate
75%
Avg EPS surprise
+2.66%
Avg 1-day reaction
+0.49%
Analysts expect McKesson to report solid earnings, with a consensus EPS of $11.57 and revenue of $101.3 billion. The market is keenly watching for any signs of growth in key segments.
Bull case
If McKesson beats EPS estimates and shows strong revenue growth, it could signal robust demand and operational efficiency, leading to a positive stock reaction.
Bear case
Conversely, if the company misses earnings expectations or provides weak guidance, it may raise concerns about its growth prospects and lead to a significant stock decline.
Key metrics to watch
EPS
$11.57Earnings per share is a key indicator of profitability and is closely watched by investors.
Revenue
$101.3BTotal revenue reflects the company's sales performance and overall growth trajectory.
The print will turn on these.
Q1
Will McKesson's EPS exceed the consensus estimate of $11.57?
A beat on EPS could indicate strong operational performance and may lead to positive market sentiment.
Q2
What guidance will McKesson provide for the upcoming quarters?
Forward-looking guidance is critical for assessing the company's growth trajectory and could significantly impact investor confidence.
Est. EPS
$0.93
Est. Rev
$839M
Impl. Move
±7.5%
Why consensus could be wrong
The Street may be underestimating McKesson's ability to leverage its scale and operational efficiencies, which could lead to stronger-than-expected earnings.
Supporting evidence
The company's recent EPS surprises indicate a potential for continued outperformance.
Options pricing suggests a higher expected move than historical averages, indicating potential volatility that the consensus may not fully appreciate.
Key risk
If EPS comes in below $11.45, it could undermine the bullish sentiment surrounding the stock.
Pre-commit to what would confirm each case.
This quarter, the focus is on whether McKesson can maintain its growth momentum amidst a challenging health care environment.
Bull confirmed if
An EPS of $12.00 or higher would confirm strong demand and operational efficiency.
Bear confirmed if
An EPS below $11.45 would raise concerns about growth and profitability.
What the market is pricing for the move.
Implied Move
±8.27%
Historical Avg
±2.7%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±8.3% while MCK has averaged ±2.7% over the last 8 prints — setup is pricing rich.
ATM IV
0.6%
30d HV
27.0%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: X of Y (Z%)
This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 5.9%, with a raw directional average of -0.5% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
93.57%
of float
Insider
0.06%
of float
Holders
2,662
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
10,795,054 sh · $9.8B
9.26%
-5.5%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If McKesson beats expectations, history suggests the stock could rise, potentially confirming a positive outlook with an average 1-day move of -0.49%.
In line / cautious
If results are in line with expectations, the stock may see muted reactions as investors await further clarity from management.
Miss
A miss could lead to a decline, with history indicating an average 1-day move of +0.70% when results fall short.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
2
1 buy·1 sell
Members
2
House only
Est. Notional
$2,002.00–$30,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Capital Management LLC
7,853,137 sh · $7.1B
6.74%
-1.4%
State Street Corporation
5,727,118 sh · $5.2B
4.91%
-0.1%
Morgan Stanley
5,306,142 sh · $4.8B
4.55%
130.7%
Franklin Resources, Inc.
2,905,114 sh · $2.6B
2.49%
-5.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net buying
1 trade
Net selling
Recent Transactions
Traded Jul 8, 2026 · disclosed Jul 12, 2026
$1,001.00–$15,000.00
Traded Jun 15, 2026 · disclosed Jul 15, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.